类风湿关节炎别只关心炎症了,骨质疏松也不可小觑!

2022-07-15 风湿免疫关爱圈 网络

类风湿是骨质疏松的高危因素,在治疗时应该随时关注患者的骨骼健康。

类风湿关节炎(RA)作为最常见的一种风湿病,首发症状一般都以关节疼痛为主,这就让很多风湿病的朋友们对关节炎症的问题非常上心,从而忽视了其他方面的问题,其中就包括骨质疏松。

 

 

骨质疏松是RA常见的并发症之一,是以骨微结构退化、骨皮质变薄、骨小梁减少、骨密度和强度减低为特征的全身性骨病 ;骨质疏松导致RA患者相较于正常人群有更高的骨折风险,增加了RA的致残率和病死率[1]

 

RA为什么会合并骨质疏松?

 

RA合并骨质疏松的原因主要有以下三个方面:

 

炎症原因:骨的正常代谢依赖骨形成和骨吸收过程的动态平衡[1],在类风湿关节炎的活动期,大量的炎症因子会导致破骨细胞活跃,成骨细胞被抑制,打破人体骨形成与骨吸收平衡,从而导致骨质疏松症的情况。

 

营养不良:类风湿关节炎的患者多数有关节疼痛、功能障碍、活动受限的情况,当病情急性发作时,患者往往会暂时丧失生活能力,没有办法走路、运动,从而引起骨营养不良,导致骨质疏松症的情况。

 

 

药物原因:糖皮质激素是类风湿关节炎患者在临床上应用比较多的一类药物,它具有强大抗炎作用可以降低类风湿患者的疾病活动性,但另一方面它也会通过降低成骨细胞和骨细胞的活性对骨重塑产生不利影响[2],从而导致药物性骨质疏松的产生。

 

骨质疏松如何正确应对?

 

安全用药:类风湿关节炎患者因激素导致的骨质疏松主要与激素的使用时长和剂量有关系,所以在用药过程中,类风湿患者一定要根据医生的诊断下规范用药,尽量使用小剂量的激素,并在病情稳定后,科学减停激素。

 

 

在药物的选择上,也可以优先选择具有骨保护作用的药物,例如艾拉莫德。艾拉莫德是一种新型抗风湿药物,主要抑制炎症反应因子,减少免疫球蛋白和自身抗体的产生;在骨代谢方面,其能够直接作用抑制破骨细胞的形成,通过调节RANK/RANKL/骨质疏松G系统抑制骨吸收,促进骨合成代谢 ;并且其不仅能够抑制骨质破坏,还能通过抑制MMP-1和 MMP-3 保护关节软骨,调节骨代谢平衡[3]

 

戒烟戒酒:烟草中所含的尼古丁可以让骨骼的滋养血管收缩,减少骨骼的血液循环,缺血后会造成新生的骨骼减少,从而引起骨质疏松症。而长期饮酒会导致胃肠道内的钙质吸收受阻,并且可能会导致维生素D的吸收与合成受到影响,从而诱发骨质疏松。因此对于类风湿关节炎的患者来说,戒烟戒酒对于保护关节来说是势在必行的。

 

适当运动:运动过程中,神经内分泌调节能够给骨骼提供充足的矿物营养,使全身的骨骼和局部的骨钙增加含量,而且在运动的时候,还能对骨骼产生一定的机械刺激,刺激成骨细胞的活性,增加骨的形成[4]

 

 

多晒太阳:太阳中的紫外线,能够使皮肤中的一种酶物质转化生成维生素D。而维生素D对肌肉骨骼健康至关重要,可以促进肠道对钙、磷的吸收,缓解骨质疏松。

向上滑动阅览

 

温馨提醒:本文基于疾病科普分享,不能代替医院就诊。意见仅供参考,具体治疗方式请遵医嘱。

责任编辑:互助君

封面图片来源:摄图网

文章来源:问问风湿APP

文章作者:张葵

参考文献:

[1]曾婷婷,田永建,谭立明,余建林,吴洋,蒋永清,陈娟娟,李华,余乐.类风湿关节炎骨质疏松危险因素分析[J].中国骨质疏松杂志,2019,25(01):74-78+84.

[2]关欣,王秀茹,王宽婷,韩淑玲,丁艳,董红宇.类风湿关节炎患者骨质疏松症患病及治疗现状[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(01):22-26.

[3]于晶晶,李慧敏,马瑞瑞,吴天进,应振华.类风湿关节炎合并骨质疏松的发病机制和治疗进展[J].中国现代医学杂志,2020,30(24):51-56.

[4]蔡东哲,惠礽华,孟祥奇.骨质疏松症的病因病机研究进展[J].中国中医骨伤科杂志,2012,20(12):76-78.

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232697, encodeId=f201123269e40, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7e82338464, createdName=12286003m71暂无昵称, createdTime=Fri Jul 15 22:30:46 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266492, encodeId=1bfa1266492f6, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334393, encodeId=7007133439389, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592719, encodeId=c3b71592e1949, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597444, encodeId=d840159e44482, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
    2022-07-15 12286003m71暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1232697, encodeId=f201123269e40, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7e82338464, createdName=12286003m71暂无昵称, createdTime=Fri Jul 15 22:30:46 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266492, encodeId=1bfa1266492f6, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334393, encodeId=7007133439389, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592719, encodeId=c3b71592e1949, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597444, encodeId=d840159e44482, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
    2022-07-11 lmm397
  3. [GetPortalCommentsPageByObjectIdResponse(id=1232697, encodeId=f201123269e40, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7e82338464, createdName=12286003m71暂无昵称, createdTime=Fri Jul 15 22:30:46 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266492, encodeId=1bfa1266492f6, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334393, encodeId=7007133439389, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592719, encodeId=c3b71592e1949, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597444, encodeId=d840159e44482, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1232697, encodeId=f201123269e40, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7e82338464, createdName=12286003m71暂无昵称, createdTime=Fri Jul 15 22:30:46 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266492, encodeId=1bfa1266492f6, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334393, encodeId=7007133439389, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592719, encodeId=c3b71592e1949, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597444, encodeId=d840159e44482, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
    2022-07-11 Eleven17
  5. [GetPortalCommentsPageByObjectIdResponse(id=1232697, encodeId=f201123269e40, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7e82338464, createdName=12286003m71暂无昵称, createdTime=Fri Jul 15 22:30:46 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266492, encodeId=1bfa1266492f6, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334393, encodeId=7007133439389, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592719, encodeId=c3b71592e1949, content=<a href='/topic/show?id=6dc2101853ed' target=_blank style='color:#2F92EE;'>#骨质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101853, encryptionId=6dc2101853ed, topicName=骨质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d018108513, createdName=Eleven17, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597444, encodeId=d840159e44482, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Mon Jul 11 02:22:42 CST 2022, time=2022-07-11, status=1, ipAttribution=)]

相关资讯

类风湿关节炎损伤的“信号灯”CCP

今为行进一步治疗来我院,门诊以“类风湿性关节炎上腹部不适查因”收住我科。此次发病来,神志清,精神差,饮食、睡眠差,大小便无异常,体重无变化,体力下降。

Arthritis Rheumatol:类风湿关节炎与冠状动脉疾病和卒中风险的遗传易感性

该研究发现类风湿性关节炎的遗传倾向与冠心病和脑出血的风险增加相关,而这可能是由CRP介导的。应积极监测和管理类风湿性关节炎患者升高的心血管风险,这可能包括抑制全身炎症。

李菁教授:为什么甲氨蝶呤如此经典&甲氨蝶呤如何安全用药?

甲氨蝶呤作为风湿科经典的抗风湿药物,也是类风湿关节炎治疗研究的金标准。为什么甲氨蝶呤能有如此的“江湖地位”?

不止红斑狼疮!羟氯喹还可以治疗这些风湿病

细数羟氯喹在风湿免疫领域的使用。

Arthritis Res Ther: 靶向治疗对老年类风湿关节炎患者安全有效

HI患者总体IR随年龄增长而增加。在调整了患者特点和合并治疗后,TT组与MTX组相比,老年和高龄患者HI的风险没有升高。

王炎焱教授:类风关患者使用甲氨蝶呤效果不好怎么办?

甲氨蝶呤作为类风湿治疗的基石药物,为什么会有人使用甲氨蝶呤效果不明显?如何处理?